ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,210Medicare Part D Prescriptions Filled, Including Refills

Rank: 486 out of 1456

$543K Total Retail Price of All Prescriptions

Rank: 394 out of 1456

454 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 454 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

15% of this provider’s 454 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

3% of this provider’s 6,649 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
LEVOTHYROXINE SODIUM 561 498 1 4
AMLODIPINE BESYLATE 318 263 2 1
HYDROCODONE-ACETAMINOPHEN 223 116 S3 3 6
SIMVASTATIN 211 202 4 2
OMEPRAZOLE 210 173 5 5
LOSARTAN POTASSIUM 185 163 6 16
LISINOPRIL 167 135 7 3
CITALOPRAM HBR 151 126 8 22
METOPROLOL TARTRATE 148 119 9 12
PRAVASTATIN SODIUM 134 127 10 9
FUROSEMIDE 129 117 11 7
MELOXICAM 123 111 12 30
GLYBURIDE 117 90 R 13 94
METFORMIN HCL 114 82 14 8
GABAPENTIN 114 97 14 13
NEXIUM 107 87 16 23
ATORVASTATIN CALCIUM 100 86 17 11
ZOLPIDEM TARTRATE 91 46 18 14
METOPROLOL SUCCINATE 90 77 19 19
CARVEDILOL 89 77 20 20
CLONIDINE HCL 86 67 21 39
CRESTOR 83 77 22 26
CYMBALTA 80 45 23 52
TRAMADOL HCL 73 41 24 17
ATENOLOL 69 52 25 18
LOSARTAN-HYDROCHLOROTHIAZIDE 67 60 26 41
GLIMEPIRIDE 66 48 27 33
SYNTHROID 66 66 27 37
HYDROCHLOROTHIAZIDE 64 55 29 10
DONEPEZIL HCL 62 51 30 29
NAMENDA 61 61 31 38
TRAZODONE HCL 59 43 32 47
DIOVAN 58 51 33 35
WARFARIN SODIUM 58 54 33 21
KLOR-CON M20 56 39 35 51
ALLOPURINOL 56 44 35 31
AZITHROMYCIN 56 43 35 44
SERTRALINE HCL 55 55 38 25
PANTOPRAZOLE SODIUM 55 47 38 43
POTASSIUM CHLORIDE 55 50 38 15
PREDNISONE 54 46 41 42
FENOFIBRATE 54 29 41 56
CIPROFLOXACIN HCL 53 41 43 58
FLUTICASONE PROPIONATE 52 44 44 28
ALENDRONATE SODIUM 51 49 45 36
OXYBUTYNIN CHLORIDE ER 51 44 45 167
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 9, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.